Skip to main content
. 2020 Dec 17;36(8):827–839. doi: 10.1007/s10654-020-00705-5

Table 5.

Multivariable-adjusteda hazard ratios (HR) and 95% confidence intervals for endometrial cancer in relation to estrogen (E) and progestin (P) average dose and potency in the Nurses’ Health Study II (1989–2017)

Person-years Cases Including never OC users Restricted to ever OC users
HR 95% CI HR 95% CI
E average dose
 Never OC use 344,113 175 1.00 (ref.)
 E dose < median 1,363,352 439 0.77 (0.64–0.92) 1.00 (ref.)
 E dose ≥ median 211,119 113 0.80 (0.62–1.02) 1.03 (0.83–1.28)
P average dose
 Never OC use 344,113 175 1.00 (ref.)
 P dose < median 817,980 246 0.75 (0.61–0.91) 1.00 (ref.)
 P dose ≥ median 764,521 312 0.80 (0.66–0.97) 1.07 (0.90–1.26)
E and P average dose
 Never OC use 344,113 175 1.00 (ref.)
 Both E and P doses < median 788,189 221 0.71 (0.58–0.87) 1.00 (ref.)
 E dose < and P dose ≥ median 575,164 218 0.83 (0.68–1.02) 1.17 (0.97–1.41)
 E dose ≥ and P dose < median 23,219 19 1.26 (0.78–2.03) 1.76 (1.09–2.84)
 Both E and P doses ≥ median 187,900 94 0.74 (0.57–0.96) 1.04 (0.81–1.34)
 p-het 0.03 0.01
E average potency
 Never OC use 344,113 175 1.00 (ref.)
 E potency < median 744,667 223 0.76 (0.62–0.94) 1.00 (ref.)
 E potency ≥ median 700,808 258 0.74 (0.61–0.90) 0.97 (0.81–1.16)
P average potency
 Never OC use 344,113 175 1.00 (ref.)
 P potency < median 887,756 242 0.75 (0.61–0.91) 1.00 (ref.)
 P potency ≥ median 565,585 245 0.77 (0.63–0.94) 1.03 (0.85–1.23)
E and P average potency
 Never OC use 344,113 175 1.00 (ref.)
 Both E and P potencies < median 519,934 148 0.78 (0.62–0.97) 1.00 (ref.)
 E potency < and P potency ≥ median 224,904 75 0.74 (0.56–0.98) 0.96 (0.72–1.27)
 E potency ≥ and P potency < median 361,709 88 0.68 (0.52–0.88) 0.87 (0.67–1.13)
 Both E and P potencies ≥ median 339,099 170 0.78 (0.63–0.97) 1.01 (0.80–1.27)
 p-het 0.26 0.95

aAdjusted for age (months), calendar period, BMI (kg/m2, continuous), number of full-term pregnancies (continuous), smoking status (never/past/current), menopausal status (premenopausal/postmenopausal/perimenopausal or unknown), use of HT (never/ever), diagnosis of PCOS (yes/no), laparoscopically confirmed endometriosis (yes/no), age of menarche (years), and use of IUD/diaphragm (yes/no).